Pharmacological Treatment (%) | Type 1 n = 211 (48.2%) | Type 2 n = 96 (21.9%) | Type 3 n = 88 (20.1%) | Type 4 n = 29 (6.6%) | Type 5 n = 14 (3.2%) | p |
---|---|---|---|---|---|---|
Loop diuretics | 96 | 68 | 61 | 51 | 71 | <0.0001 |
Calcium channel blockers | 33 | 39 | 52 | 62 | 21 | 0.002 |
ACEi | 43 | 50 | 27 | 45 | 35 | 0.0297 |
ARBs | 11 | 16 | 11 | 7 | 2 | ns |
Clonidine | 6 | 6 | 8 | 14 | 1 | ns |
Alpha-blockers | 6 | 5 | 6 | 7 | 0 | ns |
Beta-blockers | 45 | 45 | 42 | 26 | 33 | ns |
Statin | 30 | 32 | 21 | 14 | 21 | ns |
Nitrates | 47 | 24 | 25 | 10 | 14 | <0.0001 |
Digoxin | 12 | 6 | 5 | 3 | 1 | ns |
Haemodialysis | 0 | 0 | 4 | 3 | 0 | 0.0124 |
Oral antidiabetic drugs | 13 | 20 | 15 | 14 | 0 | ns |
Insulin | 25 | 20 | 24 | 27 | 57 | ns |
Antiplatelets drugs | 80 | 82 | 88 | 93 | 78 | ns |
Anticoagulants | 17 | 10 | 9 | 7 | 2 | ns |